Pharma News

Organon launches as new global women’s health company and appoints leaders in Latin America

Home/Pharma News | Posted 23/07/2021

Organon celebrated its launch as a global women’s health company on 3 June 2021 with employees and women from around the world, as the Organon executive leadership team rings the opening bell at the New York Stock Exchange.

Prestige-Cytiva partnership and new Korean R & D facility

Home/Pharma News | Posted 09/07/2021

Singapore-based Prestige BioPharma, which specializes in the development of antibody therapeutics, is to build a new research and development (R & D) facility in the Republic of Korea and has entered a strategic partnership with Cytiva.

Theramex to market Prolia biosimilar in Europe and Australia

Home/Pharma News | Posted 25/06/2021

UK-based pharmaceutical company Theramex UK Ltd, which focuses on women’s health, has announced an agreement with India’s Enzene Biosciences Limited for the registration and commercialisation of a Prolia (denosumab) biosimilar in Europe and Australia.

AbbVie antitrust investigation and Sandoz biosimilar delay

Home/Pharma News | Posted 04/06/2021

In May 2021, following the release of a report, it was announced that AbbVie is likely to be subject to an antitrust investigation due to claims it has delayed market entry of biosimilars of Humira (adalimumab). Alvotech also raised a complaint against AbbVie after being sued over their Humira biosimilar application. In addition, the US Supreme Court denied Sandoz the ability to release its Enbrel (etanercept) biosimilar.

Merck partners with Indian drugmakers to increase access to COVID-19 drug

Home/Pharma News | Posted 21/05/2021

On 27 April 2021, Merck & Co Inc (also known as MSD Pharmaceuticals) announced that it had partnered with five Indian generic drug manufacturers to expand production and access to its experimental COVID-19 drug. 

Bevacizumab and insulin aspart non-originator biologicals to be sold in Russia

Home/Pharma News | Posted 14/05/2021

Singapore-based Prestige Biopharma (Prestige) has formed an agreement with Russian company Pharmapark to commercialize Prestige’s bevacizumab non-originator biological in Russia. Russian company Geropharm has also launched an insulin aspart non-originator biological on the market in the country.

Huons Lab and PanGen Biotech to develop denosumab biosimilar

Home/Pharma News | Posted 30/04/2021

On 20 April 2021, Korean pharmaceutical company, Huons Lab, announced the development of a denosumab biosimilar to treat osteoporosis. The company is working with PanGen Biotech and using their cell line culturing and purification technology.

PlantForm and partners in Brazil to develop pembrolizumab biosimilar

Home/Pharma News | Posted 23/04/2021

Canada-based PlantForm Corporation (PlantForm) have signed an agreement with partners in Brazil to develop a biosimilar of the cancer treatment pembrolizumab (Keytruda).

Biocon partners with Libbs for the sale of generics in Brazil

Home/Pharma News | Posted 16/04/2021

India-based biologicals specialist Biocon has formed an out-licensing agreement with Brazil-based company Libbs Farmaceutica for the sale of generic drugs in the country, marking Biocon’s entry into the Latin American market for generics.

New partnerships for Cipla and Samsung Bioepis

Home/Pharma News | Posted 09/04/2021

In March 2021, Cipla announced that its subsidiary, Cipla Gulf is expanding its partnership with Alvotech for the marketing and distribution of four biosimilar medicines in Australia and New Zealand. Samsung Bioepis also announced that it has signed a marketing partnership with Yuhan to launch its biosimilar of Humira (adalimumab), Adalloce, in South Korea.